Autoplaque vs HeartFlow Analysis
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your primary need is a workstation-based solution for precise, quantitative analysis of coronary plaque and luminal stenoses directly from CT angiography images. This tool is ideal for clinicians who require the ability to review and refine AI-generated segmentations for in-depth risk prediction and treatment guidance based on detailed plaque morphology.
View Autoplaque →Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you require a comprehensive, non-invasive diagnostic assessment of coronary artery disease that integrates both quantitative plaque analysis and functional assessment via FFRct. This cloud-based solution is particularly well-suited when determining the hemodynamic significance of stenoses is critical for patient management, leveraging its established reimbursement and personalized 3D modeling.
View HeartFlow Analysis →When choosing between Autoplaque and HeartFlow Analysis, physicians should consider their primary need: detailed plaque morphology or comprehensive functional assessment. Autoplaque excels in quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, providing precise measurements and characterization of atherosclerotic plaque. It is a workstation-based software, allowing for direct clinician review and editing of automated segmentations. This tool is best suited for cardiologists and radiologists who prioritize in-depth anatomical plaque assessment and require a local, interactive post-processing application.
In contrast, HeartFlow Analysis offers a more comprehensive, non-invasive solution for diagnosing and managing coronary artery disease by creating personalized 3D models and performing Fractional Flow Reserve derived from CT (FFRct) analysis. Its cloud-based deployment and fee-for-service model, with established CPT codes and Medicare coverage, streamline integration into existing workflows. HeartFlow is ideal for physicians seeking both plaque quantification and a functional assessment of blood flow, particularly when evaluating the hemodynamic significance of stenoses without invasive procedures. The key practical difference lies in Autoplaque’s focus on detailed, workstation-based plaque morphology versus HeartFlow’s broader, cloud-based functional assessment including FFRct.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | HeartFlow Analysis |
|---|---|---|
| Pricing | Not disclosed | Contact vendor for pricing |
| Deployment | Workstation-based software, runs on Windows or Mac computer platforms | Cloud-based (AWS) |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieAutoplaque is workstation-based, offering direct control and potentially faster local processing, while HeartFlow Analysis is cloud-based, providing easier access and reduced IT overhead. Both deployment models have distinct advantages depending on the user's infrastructure and preferences, making it difficult to declare a definitive winner without specific user experience data.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis offers a more comprehensive clinical assessment by integrating Fractional Flow Reserve derived from CT (FFRct) and Computational Fluid Dynamics (CFD) to evaluate the functional significance of stenoses, going beyond the quantitative anatomical plaque analysis provided by Autoplaque. This provides a deeper level of insight for diagnosis and management of coronary artery disease.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis offers a significantly clearer value proposition due to its established reimbursement pathway, including Category I CPT codes for FFRct Analysis and AI-Enabled Quantitative Plaque Analysis, and established CMS payment rates. Autoplaque's undisclosed pricing makes its economic value difficult to ascertain for healthcare providers.
Enterprise Readiness
HeartFlow AnalysisHeartFlow Analysis demonstrates stronger enterprise readiness with its explicit HIPAA compliance, availability of a Business Associate Agreement (BAA), and cloud-based deployment, which are crucial for integration and addressing data security and privacy requirements in healthcare organizations. Autoplaque's lack of specified compliance details and workstation deployment present potential hurdles for large-scale enterprise adoption.
Innovation
HeartFlow AnalysisHeartFlow Analysis exhibits greater innovation by integrating advanced computational fluid dynamics and FFRct analysis with AI to provide a functional assessment of blood flow, which is a more sophisticated application than Autoplaque's quantitative anatomical analysis. This provides a deeper and more predictive insight into coronary artery disease.
Support & Docs
HeartFlow AnalysisAs a commercial entity, HeartFlow provides clinical evidence, user resources, and contact information for support on its website, indicating a more formalized and publicly accessible support and documentation infrastructure. Autoplaque, being a product from a medical center's AI division, appears to have less publicly defined support channels.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | HeartFlow Analysis |
|---|---|---|
| Product Name | Autoplaque | HeartFlow Analysis |
| Company | Cedars-Sinai Medical Center: AIM | HeartFlow |
| Tagline | AI-Powered Quantitative Analysis for Coronary Plaque and Stenosis | Decisive Coronary Care |
| Core Plaque Analysis | AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Automated vessel, plaque, and lumen segmentation | Plaque Analysis (quantification and characterization) |
| Luminal Stenosis Measurement | Measurement of luminal stenoses; Measurement of vessel diameter and area | Not specified |
| Advanced Hemodynamic Analysis | Not specified | Fractional Flow Reserve derived from CT (FFRct) analysis; Computational Fluid Dynamics (CFD) for blood flow simulation |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and HeartFlow Analysis.